Have You experienced Novantrone side effects? Select to Vote Yes, Severe Yes, Moderate Yes, Minor No View and Discuss Results

1.5 million people annually are harmed from drug errors. Don't Risk Your Health! Ask a Health Expert Now

From simple mix-ups to fatal overdoses, medication mistakes happen, on average, once a day to every hospital patient, a new report says. Nationwide, at least 1.5 million people annually are harmed from drug errors, more than half of them in nursing homes.
Many Unfavorable Drug Studies Aren’t Published. Nearly a third of antidepressant drug studies are never published in the medical literature, and nearly all of those happen to show that the drug being tests failed to work.
Only Drugs That are Safe Should be put on the Market. Drug developers are just beginning to come to grips with recent FDA oversight reforms and how they will affect drug safety. But, it appears that industry and consumer advocates are not together on how well the overhaul will be able to prevent future drug safety scandals.

      Advertisements

Health Experts answered these questions:

My wife has arthritis,quite severe. if she sustains a bruise or a cut the results last for weeks or even months. she bruises badly with the slightest...
I was up last night having to use the bathroom with diarrhea for about an hour. This morning i woke up and i felt like i was going to throw up and i h...
Do You Have a Health Question about Novantrone? Ask a Health Expert!

Vaccine Safety

Menu

• Novantrone: Ask Health Expert
• Novantrone: Ask Legal Expert
• Novantrone Usage
• Describe Your Side Effect
• FDA Warnings
• Avoid Medication Mistakes
• Novantrone Safety Poll
• Novantrone: Share Your Health Story
• Novantrone: Take Side Effects Survey and View Results
• Take Symptoms Survey and View Results
• Patient Wiki: Stories, Blogs, Surveys
• Hospital Quality Reports
• Home Care Quality

Community-reported Novantrone side effects:

Add Your Side Effect to the Community Database

Help Community - Describe Your Novantrone Side Effect Episode

Have You dealt with a Novantrone side effect? Share your experience

A Health Expert wants to answer your Novantrone question. Please provide details below. Type your question here

 letters left

Review Novantrone Safety Reports submitted to FDA

Total Novantrone reports: 312.
Novantrone FDA safety alerts: 2005 .
Reported deaths: 100    Reported hospitalizations: 155.
Take Novantrone Side Effects Survey, Discuss Novantrone with others
FDA Reported Novantrone Side Effects: ejection fraction decreased, febrile neutropenia, acute myeloid leukaemia, septic shock, cardiac failure congestive, platelet count decreased, diarrhoea, anaemia, pancytopenia, myocardial infarction, neutropenia.
Novantrone Usage.
If you have questions about Novantrone, you can ask a Health Expert or Ask Patient Community about Novantrone.

Showing 1-100 of 312 Next >

Novantrone Side Effects Report #5298628-2
Consumer or non-health professional from UNITED STATES reported NOVANTRONE problem on Mar 27, 2007. Male patient, 63 years of age, weighting 149.9 lb, was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, clostridium difficile colitis, coronary artery occlusion, coronary artery stenosis, dilatation atrial, no therapeutic response, procedural hypotension, ventricular hypertrophy. NOVANTRONE dosage: 21 MG, 1 IN 3 MONTHS. During the same period patient was treated with FELODIPINE, ACETYLSALICYLIC ACID SRT, BENAZEPRIL HYDROCHLORIDE, MORNIFLUMATE, SIMVASTATIN, TEMAZEPAM, GABAPENTIN, IBUPROFEN. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5299729-5
NOVANTRONE problem was reported by a Consumer or non-health professional from JAPAN on Apr 02, 2007. Male patient, 51 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, anaemia, disseminated intravascular coagulation, dysphagia, hepatic function abnormal, herpes simplex, hypoalbuminaemia, hypokalaemia, mouth haemorrhage. NOVANTRONE dosage: unknown. During the same period patient was treated with MYLOTARG, CYTARABINE, POLYMYXIN B SULPHATE, FAMOTIDINE, BACTRIM, ALLOPURINOL, VORICONAZOLE. Patient was hospitalized. Patient died on 10/15/2006.

Novantrone Side Effects Report #5299731-3
Consumer or non-health professional from UNITED STATES reported NOVANTRONE problem on Mar 29, 2007. Male patient, 64 years of age, was diagnosed with prostate cancer and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, dyspnoea, malignant neoplasm progression, prostate cancer. NOVANTRONE dosage: 12 MG/M2, 1 IN 21 DAYS, INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with DOCETAXEL, IROFULVEN, CAPECITABINE. Patient died.

Novantrone Side Effects Report #5302418-1
NOVANTRONE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 05, 2007. Male patient, child 7 years of age, was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: anaemia, cardiac failure, chills, disseminated intravascular coagulation, hepatic function abnormal, hypoxia, pericardial effusion, pleural effusion, tumour lysis syndrome. NOVANTRONE dosage: unknown. During the same period patient was treated with MYLOTARG, IDARUBICIN, PIRARUBICIN, CYTARABINE, LENOGRASTIM. Patient was hospitalized. Patient died on 03/29/2006.

Novantrone Side Effects Report #5305083-2
Consumer or non-health professional from UNITED STATES reported NOVANTRONE problem on Apr 09, 2007. Female patient, 49 years of age, weighting 130.0 lb, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, extrasystoles, nausea, osteoporosis. NOVANTRONE dosage: 19 MG, 1 IN 3 MONTHS, INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with BACLOFEN, DECADRON. Patient recovered.

Novantrone Side Effects Report #5305120-5
NOVANTRONE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 07, 2007. Female patient, 46 years of age, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: malaise, vomiting. NOVANTRONE dosage: unknown. During the same period patient was treated with REBIF. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5306507-7
Consumer or non-health professional from JAPAN reported NOVANTRONE problem on Apr 10, 2007. Female patient, 83 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, febrile neutropenia, pneumonia. NOVANTRONE dosage: 6 MG, 1 IN 1 DAYS, INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with MYLOTARG, CYTARABINE, FLUDARABINE PHOSPHATE, FLUCONAZOLE, AMPHOTERICIN B, LEVOFLOXACIN, ITRACONAZOLE. Patient recovered.

Novantrone Side Effects Report #5306508-9
NOVANTRONE problem was reported by a Consumer or non-health professional from ITALY on Apr 10, 2007. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: pulmonary alveolar haemorrhage. NOVANTRONE dosage: 39 MG. During the same period patient was treated with CYTARABINE, ETOPOSIDE. Patient recovered.

Novantrone Side Effects Report #5306509-0
Consumer or non-health professional from FRANCE reported NOVANTRONE problem on Apr 06, 2007. Female patient, 52 years of age, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: hypersensitivity. NOVANTRONE dosage: 20 MG, 1 IN 1 DAYS, INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with REBIF, METHYLPREDNISOLONE SUCCINATE. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5306519-3
NOVANTRONE problem was reported by a Consumer or non-health professional from JAPAN on Apr 12, 2007. Male patient, 62 years of age, was diagnosed with acute myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, hyperphosphataemia, renal impairment. NOVANTRONE dosage: unknown. During the same period patient was treated with MYLOTARG, CYTARABINE, IDARUBICIN. Patient recovered.

Novantrone Side Effects Report #5307759-X
Health Professional from UNITED STATES reported NOVANTRONE problem on Apr 09, 2007. Female patient, 43 years of age, weighting 120.0 lb, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: catheter related infection, sepsis. NOVANTRONE dosage: unknown. During the same period patient was treated with REBIF. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5309160-1
NOVANTRONE problem was reported by a Health Professional from UNITED STATES on Apr 09, 2007. Female patient, 42 years of age, weighting 135.0 lb, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased. NOVANTRONE dosage: unknown. During the same period patient was treated with REBIF, IBUPROFEN. Patient recovered.

Novantrone Side Effects Report #5312815-6
Consumer or non-health professional from UNITED STATES reported NOVANTRONE problem on Apr 10, 2007. Female patient, 53 years of age, weighting 180.8 lb, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: chest pain, dyspnoea, ejection fraction decreased. NOVANTRONE dosage: unknown. During the same period patient was treated with KEPPRA, ANTIDEPRESSANTS. Patient recovered.

Novantrone Side Effects Report #5313506-8
NOVANTRONE problem was reported by a Consumer or non-health professional from JAPAN on Apr 18, 2007. Male patient, 28 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, anaemia, chills, condition aggravated, diarrhoea, epistaxis, headache, hepatic function abnormal, mucous membrane disorder. NOVANTRONE dosage: unknown. During the same period patient was treated with MYLOTARG, CYTARABINE, IDARUBICIN, GRANISETRON, HYDROCORTISONE SUCCINATE, HEPARIN. Patient was hospitalized. Patient died on 09/02/2006.

Novantrone Side Effects Report #5313509-3
Consumer or non-health professional from JAPAN reported NOVANTRONE problem on Apr 12, 2007. Male patient, 56 years of age, was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, anaemia, blood alkaline phosphatase abnormal, disease progression, febrile neutropenia, gingival bleeding, hypersensitivity, hypoalbuminaemia, lymphocyte count decreased. NOVANTRONE dosage: unknown. During the same period patient was treated with MYLOTARG, CYTARABINE, ENOCITABINE, KELFIPRIM, ITRACONAZOLE, ALLOPURINOL. Patient recovered.

Novantrone Side Effects Report #5315173-6
NOVANTRONE problem was reported by a Consumer or non-health professional from GERMANY on Apr 18, 2007. Female patient, 51 years of age, was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: accidental exposure, atrioventricular block complete, breast pain, contusion, dyspnoea, facial bones fracture, fall, loss of consciousness, nausea. NOVANTRONE dosage: unknown. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5315177-3
Consumer or non-health professional from GERMANY reported NOVANTRONE problem on Apr 20, 2007. Male patient, 69 years of age, was diagnosed with acute myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: blood culture positive, bronchopulmonary aspergillosis, respiratory failure, staphylococcal infection. NOVANTRONE dosage: 14 MG. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient died on 04/12/2004.

Novantrone Side Effects Report #5315183-9
NOVANTRONE problem was reported by a Consumer or non-health professional from GERMANY on Apr 20, 2007. Male patient, 72 years of age, was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: peritoneal effusion, pleural effusion, pneumonia fungal, sepsis. NOVANTRONE dosage: 14 MG, INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with CYTARABINE, ETOPOSIDE. Patient died on 09/27/2006.

Novantrone Side Effects Report #5315184-0
Consumer or non-health professional from ITALY reported NOVANTRONE problem on Apr 20, 2007. Male patient, 67 years of age, was diagnosed with acute myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: hepatic failure, sepsis. NOVANTRONE dosage: 10 MG, INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with CYTARABINE, ETOPOSIDE, INSULIN. Patient died on 04/06/2007.

Novantrone Side Effects Report #5315185-2
NOVANTRONE problem was reported by a Consumer or non-health professional from GERMANY on Apr 19, 2007. Male patient, 65 years of age, was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: fungal infection. NOVANTRONE dosage: 14 MG. During the same period patient was treated with CYTARABINE, ETOPOSIDE. Patient died on 07/03/2005.

Novantrone Side Effects Report #5315264-X
Consumer or non-health professional from UNITED STATES reported NOVANTRONE problem on Apr 18, 2007. Male patient, 51 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, anaemia, disseminated intravascular coagulation, dysphagia, dysphasia, eating disorder, hepatic function abnormal, herpes simplex. NOVANTRONE dosage: unknown. During the same period patient was treated with MYLOTARG, CYTARABINE, POLYMYXIN B SULPHATE, FAMOTIDINE, BACTRIM, ALLOPURINOL, VORICONAZOLE. Patient was hospitalized. Patient died on 10/15/2006.

Novantrone Side Effects Report #5319913-1
NOVANTRONE problem was reported by a Consumer or non-health professional from GERMANY on Apr 24, 2007. Male patient, 70 years of age, was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. NOVANTRONE dosage: 12.7 MG, ONCE, INTRAVENOUS. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, CYTARABINE, ETOPOSIDE, PREDNISONE. Patient died on 06/27/2005.

Novantrone Side Effects Report #5322666-4
Physician from UNITED STATES reported NOVANTRONE problem on Apr 23, 2007. Female patient, 46 years of age, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: atelectasis, febrile neutropenia, pulmonary embolism, urinary tract infection, vomiting. NOVANTRONE dosage: unknown. During the same period patient was treated with REBIF, ZOLOFT, BACLOFEN, VESICARE, BACLOFEN PUMP, PROVIGIL. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5323078-X
NOVANTRONE problem was reported by a Health Professional from UNITED STATES on Apr 25, 2007. Male patient, 42 years of age, weighting 140.0 lb, was diagnosed with acute myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, acute respiratory failure, bacterial infection, blood culture positive, blood ph decreased, clostridium difficile colitis, constipation, enterocolitis infectious. NOVANTRONE dosage: unknown. During the same period patient was treated with ETOPOSIDE, CYTARABINE. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5323655-6
Consumer or non-health professional from GERMANY reported NOVANTRONE problem on Apr 26, 2007. Female patient, 48 years of age, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: anxiety, hallucination, nausea, nightmare, persecutory delusion. NOVANTRONE dosage: 17 MG, INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with METOCLOPRAMIDE, ONDANSETRON, CITALOPRAM HYDROBROMIDE, PREDNISONE. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5324238-4
NOVANTRONE problem was reported by a Consumer or non-health professional from SWEDEN on Apr 26, 2007. Female patient, 13 years of age, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, cardiac failure, cardiotoxicity, nausea. NOVANTRONE dosage: 12MG/M2, 1 IN 3 MONTHS, INTRAVENOUS (NOT OTHERWISE SPECIFIED). Patient recovered.

Novantrone Side Effects Report #5330106-4
Physician from UNITED STATES reported NOVANTRONE problem on May 02, 2007. Female patient was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: acute promyelocytic leukaemia, pancytopenia. NOVANTRONE dosage: 5 MG/M2, 3 IN 1 MONTHS, INTRAVENOUS. During the same period patient was treated with REBIF, CELLCEPT. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5330108-8
NOVANTRONE problem was reported by a Physician from UNITED STATES on May 07, 2007. Female patient, 29 years of age, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia. NOVANTRONE dosage: unknown. During the same period patient was treated with REBIF, METHYLPREDNISOLONE. Patient recovered.

Novantrone Side Effects Report #5330176-3
Physician from UNITED STATES reported NOVANTRONE problem on May 01, 2007. Female patient was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: chronic myeloid leukaemia. NOVANTRONE dosage: 12 MG/M2, 1 IN 3 MONTHS, NOT REPORTED. Patient recovered.

Novantrone Side Effects Report #5330181-7
NOVANTRONE problem was reported by a Consumer or non-health professional from UNITED STATES on May 05, 2007. Female patient, 45 years of age, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: gallbladder disorder, pain. NOVANTRONE dosage: unknown. During the same period patient was treated with KEPPRA, TOPAMAX, SEROQUEL, ZANAFLEX, BACLOFEN, NEURONTIN, LYRICA. Patient recovered.

Novantrone Side Effects Report #5330182-9
Health Professional from UNITED STATES reported NOVANTRONE problem on May 03, 2007. Female patient, 55 years of age, weighting 185.2 lb, was diagnosed with acute myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, haematocrit decreased, haemoglobin decreased, platelet count decreased, pyrexia, white blood cell count decreased. NOVANTRONE dosage: unknown. During the same period patient was treated with ETOPOSIDE, CYTARABINE. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5333505-X
NOVANTRONE problem was reported by a Consumer or non-health professional from UNITED STATES on May 08, 2007. Female patient, 49 years of age, weighting 130.0 lb, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, extrasystoles, nausea, osteoporosis. NOVANTRONE dosage: 19 MG, 1 IN 3 MONTHS, INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with BACLOFEN, DECADRON. Patient recovered.

Novantrone Side Effects Report #5334422-1
Consumer or non-health professional from UNITED STATES reported NOVANTRONE problem on May 09, 2007. Male patient, 35 years of age, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased. NOVANTRONE dosage: unknown. During the same period patient was treated with REBIF, LORTAB. Patient recovered.

Novantrone Side Effects Report #5334429-4
NOVANTRONE problem was reported by a Physician from UNITED STATES on May 09, 2007. Female patient, 60 years of age, weighting 170.0 lb, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: carbohydrate antigen 125 increased, clostridial infection, ovarian cancer, weight decreased, white blood cell count decreased. NOVANTRONE dosage: unknown. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5334449-X
Consumer or non-health professional from UNITED STATES reported NOVANTRONE problem on May 14, 2007. Female patient, 42 years of age, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. NOVANTRONE dosage: unknown. Patient died on 04/20/2007.

Novantrone Side Effects Report #5334483-X
NOVANTRONE problem was reported by a Consumer or non-health professional from UNITED STATES on May 08, 2007. Female patient, 46 years of age, weighting 118.0 lb, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased. NOVANTRONE dosage: unknown. During the same period patient was treated with REBIF, FLUOXETINE. Patient recovered.

Novantrone Side Effects Report #5334497-X
Health Professional from UNITED STATES reported NOVANTRONE problem on May 11, 2007. Male patient, 42 years of age, weighting 140.0 lb, was diagnosed with acute myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: acute respiratory failure, bacterial infection, blood ph decreased, clostridium difficile colitis, constipation, full blood count decreased, hypovolaemia, megacolon, mucosal inflammation. NOVANTRONE dosage: unknown. During the same period patient was treated with ETOPOSIDE, CYTARABINE. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5336325-5
NOVANTRONE problem was reported by a Consumer or non-health professional from UNITED STATES on May 14, 2007. Male patient, 66 years of age, weighting 153.0 lb, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased. NOVANTRONE dosage: unknown. During the same period patient was treated with AVONEX, HYZAAR, GLIPIZIDE. Patient recovered.

Novantrone Side Effects Report #5337670-X
Physician from UNITED STATES reported NOVANTRONE problem on May 15, 2007. Female patient, 45 years of age, weighting 240.0 lb, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: cholecystitis. NOVANTRONE dosage: 12 MG/M2, 1 IN 3 MONTHS, INTRAVENOUS (NOT SPECIFIED). During the same period patient was treated with KEPPRA, TOPAMAX, SEROQUEL, ZANAFLEX, BACLOFEN, NEURONTIN, LYRICA. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5341529-1
NOVANTRONE problem was reported by a Consumer or non-health professional from FRANCE on May 15, 2007. Female patient, 47 years of age, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia. NOVANTRONE dosage: 20 MG, 1 IN 1 CYCLE, INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with IMURAN. Patient recovered.

Novantrone Side Effects Report #5352101-1
Consumer or non-health professional from UNITED STATES reported NOVANTRONE problem on May 25, 2007. Female patient, 51 years of age, was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: accidental exposure, atrioventricular block complete, contusion, facial bones fracture, fall, syncope. NOVANTRONE dosage: unknown. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5352105-9
NOVANTRONE problem was reported by a Health Professional from ISRAEL on May 22, 2007. Female patient, 61 years of age, was diagnosed with myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: arrhythmia, hypokalaemia, syncope, torsade de pointes. NOVANTRONE dosage: unknown. During the same period patient was treated with GLIBLENCLAMIDE, LEVOTHYROXINE, CANDESARTAN, FLUCONAZOLE. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5353504-1
Consumer or non-health professional from BELGIUM reported NOVANTRONE problem on June 01, 2007. Male patient, 74 years of age, was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: hepatitis toxic, pneumonitis, respiratory failure. NOVANTRONE dosage: unknown. During the same period patient was treated with CYTARABINE, ETOPOSIDE. Patient was hospitalized. Patient died.

Novantrone Side Effects Report #5362970-7
NOVANTRONE problem was reported by a Consumer or non-health professional from ITALY on June 08, 2007. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: pulmonary alveolar haemorrhage. NOVANTRONE dosage: 39 MG. During the same period patient was treated with CYTARABINE, ETOPOSIDE. Patient recovered.

Novantrone Side Effects Report #5363021-0
Consumer or non-health professional from UNITED STATES reported NOVANTRONE problem on June 06, 2007. Female patient, 43 years of age, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: arterial injury. NOVANTRONE dosage: unknown. Patient recovered.

Novantrone Side Effects Report #5366652-7
NOVANTRONE problem was reported by a Physician from UNITED STATES on June 11, 2007. Female patient, 57 years of age, weighting 151.0 lb, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: chronic myeloid leukaemia. NOVANTRONE dosage: 12 MG/M2, 1 IN 3 MONTHS. During the same period patient was treated with BACLOFEN, URISPAS, CELEXA, ACTONEL, FOLIC ACID, ALLOPURINOL. Patient recovered.

Novantrone Side Effects Report #5366668-0
Consumer or non-health professional from UNITED STATES reported NOVANTRONE problem on June 06, 2007. Male patient, 22 years of age, was diagnosed with acute myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: central line infection, febrile neutropenia, hypotension, lung consolidation, oxygen saturation decreased, pleural effusion, pneumonia. NOVANTRONE dosage: 16.7 MG, 1 IN 1 DAYS, INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with ETOPOSIDE. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5366720-X
NOVANTRONE problem was reported by a Physician from UNITED STATES on June 05, 2007. Male patient, 66 years of age, weighting 135.0 lb, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, left ventricular dysfunction. NOVANTRONE dosage: 12 MG/M2, 1 IN 3 MONTHS, INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with HYZAAR, GLIPIZIDE, ALTACE, METFORMIN, LIPITOR, AVONEX, POTASSIUM CHLORIDE. Patient recovered.

Novantrone Side Effects Report #5369482-5
Health Professional from UNITED STATES reported NOVANTRONE problem on June 08, 2007. Male patient, 64 years of age, weighting 187.2 lb, was diagnosed with acute myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: dysphagia, febrile neutropenia, mucosal inflammation, oral pain, white blood cell count decreased. NOVANTRONE dosage: unknown. During the same period patient was treated with CYTARABINE, ETOPOSIDE. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5371014-2
NOVANTRONE problem was reported by a Consumer or non-health professional from UNITED STATES on June 18, 2007. Female patient, 83 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, febrile neutropenia, pneumonia. NOVANTRONE dosage: 6 MG, 1 IN 1 DAYS, INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with MYLOTARG, CYTARABINE, FLUDARABINE PHOSPHATE, FLUCONAZOLE, AMPHOTERICIN B, LEVOFLOXACIN, ITRACONAZOLE. Patient recovered.

Novantrone Side Effects Report #5372552-9
Consumer or non-health professional from JAPAN reported NOVANTRONE problem on June 18, 2007. Male patient, 45 years of age, was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: chills, febrile neutropenia, pancytopenia, pseudomembranous colitis. NOVANTRONE dosage: unknown. During the same period patient was treated with MYLOTARG, CYTARABINE, ETOPOSIDE, VANCOMYCIN, HEPARIN, BICARBONATE, INSULIN. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5375760-6
NOVANTRONE problem was reported by a Physician from UNITED STATES on June 19, 2007. Male patient, 51 years of age, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. NOVANTRONE dosage: unknown. Patient died on 06/18/2007.

Novantrone Side Effects Report #5375765-5
Health Professional from UNITED STATES reported NOVANTRONE problem on June 15, 2007. Male patient, 64 years of age, was diagnosed with off label use and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: granulocyte count decreased, neutrophil count decreased. NOVANTRONE dosage: 25 MG, 1 IN 1 DAYS, INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with IXABEPILONE, PREDNISONE, ALDACTONE, AMITRIPTYLINE, FUROSEMIDE, LORAZEPAM, OXYCODONE, OXYCONTIN. Patient recovered.

Novantrone Side Effects Report #5377879-2
NOVANTRONE problem was reported by a Health Professional from UNITED STATES on June 18, 2007. Female patient, 64 years of age, weighting 182.3 lb, was diagnosed with acute myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: dysphagia, febrile neutropenia, mucosal inflammation, oral pain, white blood cell count decreased. NOVANTRONE dosage: unknown. During the same period patient was treated with CYTARABINE, ETOPSIDE. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5047243-4
Consumer or non-health professional from UNITED STATES reported NOVANTRONE problem on June 26, 2006. Male patient, 67 years of age, was diagnosed with acute myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: bronchopulmonary aspergillosis, full blood count decreased, lung infiltration, septic shock. NOVANTRONE dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, CYTARABINE, ETOPOSIDE. Patient was hospitalized. Patient died on 11/15/2004.

Novantrone Side Effects Report #5047468-8
NOVANTRONE problem was reported by a Health Professional from UNITED STATES on June 20, 2006. Male patient, 57 years of age, weighting 244.9 lb, was diagnosed with acute myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: pancytopenia, septic shock. NOVANTRONE dosage: 18 MG, 1 IN 1 DAYS, INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with ETOPOSIDE, CYTARABINE, ACETAMINOPHEN, ALLOPURINOL. Patient died on 04/26/2006.

Novantrone Side Effects Report #5047524-4
Physician from UNITED STATES reported NOVANTRONE problem on June 22, 2006. Female patient, 42 years of age, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: asthenia, constipation, febrile neutropenia, urinary tract infection. NOVANTRONE dosage: unknown. During the same period patient was treated with BACLOFEN, DITROPAN, REBIF. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5049708-8
NOVANTRONE problem was reported by a Health Professional from UNITED STATES on June 26, 2006. Female patient, 76 years of age, was diagnosed with acute myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, infusion related reaction. NOVANTRONE dosage: 50.4 MG, 1 IN 1 DAYS,. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, CYTARABINE. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5050128-0
Consumer or non-health professional from FRANCE reported NOVANTRONE problem on June 27, 2006. Female patient, 56 years of age, was diagnosed with breast cancer female and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: granuloma annulare. NOVANTRONE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5050520-4
NOVANTRONE problem was reported by a Consumer or non-health professional from UNITED STATES on June 29, 2006. Male patient, 70 years of age, was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: blood culture positive, chills, multi-organ failure, pseudomonas infection, pyrexia, respiratory distress, septic shock. NOVANTRONE dosage: 10 MG. During the same period patient was treated with CYTARABINE, ETOPOSIDE. Patient died on 06/14/2006.

Novantrone Side Effects Report #5050521-6
Consumer or non-health professional from GERMANY reported NOVANTRONE problem on June 27, 2006. Male patient, 75 years of age, was diagnosed with acute myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: aplasia, bronchopulmonary aspergillosis. NOVANTRONE dosage: 14 MG, 1 IN 1 DAYS. During the same period patient was treated with CYTARABINE, ETOPOSIDE, VANCOMYCIN, MEROPENEM. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5055565-6
NOVANTRONE problem was reported by a Physician from UNITED STATES on July 03, 2006. Female patient, 53 years of age, weighting 152.4 lb, was diagnosed with acute myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: escherichia bacteraemia, hypotension. NOVANTRONE dosage: unknown. During the same period patient was treated with ETOPOSIDE, CYTARABINE. Patient recovered.

Novantrone Side Effects Report #5055568-1
Physician from UNITED STATES reported NOVANTRONE problem on July 06, 2006. Male patient, 62 years of age, weighting 213.8 lb, was diagnosed with acute myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. NOVANTRONE dosage: 18 MG, 1 IN 1 DAYS, INTRAVENOUS. During the same period patient was treated with ETOPOSIDE, CYTARABINE. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5055569-3
NOVANTRONE problem was reported by a Consumer or non-health professional from UNITED STATES on July 05, 2006. Female patient, 29 years of age, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: dyspnoea, ejection fraction decreased. NOVANTRONE dosage: unknown. Patient recovered.

Novantrone Side Effects Report #5055979-4
Consumer or non-health professional from UNITED STATES reported NOVANTRONE problem on July 05, 2006. Male patient, 44 years of age, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: coronary artery disease, dyspepsia, myocardial infarction. NOVANTRONE dosage: unknown. During the same period patient was treated with COPAXONE. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5055980-0
NOVANTRONE problem was reported by a Physician from UNITED STATES on July 07, 2006. Male patient, 51 years of age, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: cardiac output decreased, cardiomyopathy, exercise tolerance decreased. NOVANTRONE dosage: unknown. Patient recovered.

Novantrone Side Effects Report #5060289-5
Consumer or non-health professional from UNITED STATES reported NOVANTRONE problem on July 12, 2006. Male patient, 70 years of age, was diagnosed with acute myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, blood lactate dehydrogenase increased, electrocardiogram st segment depression, sepsis, ventricular tachycardia. NOVANTRONE dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, CYTARABINE, ETOPOSIDE, RAMIPRIL. Patient was hospitalized. Patient died on 12/12/2005.

Novantrone Side Effects Report #5062548-9
NOVANTRONE problem was reported by a Consumer or non-health professional from UNITED STATES on July 13, 2006. Female patient, 63 years of age, weighting 154.3 lb, was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased, lung infection, platelet count decreased, respiratory failure, staphylococcal infection. NOVANTRONE dosage: 12 MG. During the same period patient was treated with GEMTUZUMAB, CYTARABINE, ETOPOSIDE, LEVOFLOXACIN. Patient died on 02/02/2005.

Novantrone Side Effects Report #5065368-4
Consumer or non-health professional from UNITED STATES reported NOVANTRONE problem on July 17, 2006. Female patient, 63 years of age, weighting 150.6 lb, was diagnosed with chronic myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood urea increased, bone marrow failure, coagulopathy, disease progression, febrile neutropenia. NOVANTRONE dosage: 16 MG, 1 IN 1 DAYS, INTRAVENOUS. During the same period patient was treated with MYLOTARG, FLUDARABINE PHOSPHATE, GEMCITABINE, FLUCONAZOLE, HYDROMORPHONE HYDROCHLORIDE, LORAZEPAM, LEVOFLOXACIN, INSULIN. Patient was hospitalized. Patient died on 04/02/2003.

Novantrone Side Effects Report #5065619-6
NOVANTRONE problem was reported by a Consumer or non-health professional from UNITED STATES on July 18, 2006. Female patient, 42 years of age, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: arteriovenous fistula thrombosis, catheter related complication, intracardiac thrombus, oedema peripheral. NOVANTRONE dosage: unknown. During the same period patient was treated with PLASMAPHERESIS. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5066321-7
Physician from UNITED STATES reported NOVANTRONE problem on July 17, 2006. Male patient, 81 years of age, weighting 160.1 lb, was diagnosed with acute myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: anorexia, bacteraemia, blood alkaline phosphatase increased, blood culture positive, dysphagia, fatigue, febrile neutropenia, pancytopenia, stomatitis. NOVANTRONE dosage: unknown. During the same period patient was treated with ETOPOSIDE, CYTARABINE, ACYCLOVIR, PREDTE. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5074368-X
NOVANTRONE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 20, 2006. Female patient, 54 years of age, was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, lymphocyte count decreased, neutropenic sepsis, platelet count decreased, red blood cell count decreased. NOVANTRONE dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, TRETINOIN. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5074424-6
Consumer or non-health professional from UNITED STATES reported NOVANTRONE problem on July 19, 2006. Female patient, 40 years of age, weighting 220.5 lb, was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: chronic myeloid leukaemia. NOVANTRONE dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE. Patient recovered.

Novantrone Side Effects Report #5074547-1
NOVANTRONE problem was reported by a Physician from UNITED STATES on July 26, 2006. Male patient, 42 years of age, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: coronary artery occlusion, myocardial infarction. NOVANTRONE dosage: 21.6 MG,. During the same period patient was treated with COPAXONE. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5074553-7
Consumer or non-health professional from UNITED STATES reported NOVANTRONE problem on July 24, 2006. Male patient, 57 years of age, weighting 244.9 lb, was diagnosed with acute myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: blood culture positive, enterococcal infection, pancytopenia, septic shock, trichosporon infection. NOVANTRONE dosage: 18 MG, 1 IN 1 DAYS; INTRAVENOUS, 18 MG, 1 IN 1 DAYS; INTRAVENOUS. During the same period patient was treated with ETOPOSIDE, CYTARABINE, ACETAMINOPHEN, ACYCLOVIR, ALLOPURINOL, AZTREONAM. Patient was hospitalized. Patient died on 04/26/2006.

Novantrone Side Effects Report #5074587-2
NOVANTRONE problem was reported by a Consumer or non-health professional from UNITED STATES on July 25, 2006. Male patient, 62 years of age, weighting 213.8 lb, was diagnosed with acute myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. NOVANTRONE dosage: 18 MG, 1 IN 1 DAYS, INTRAVENOUS. During the same period patient was treated with ETOPOSIDE, CYTARABINE. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5075911-7
Pharmacist from UNITED STATES reported NOVANTRONE problem on Aug 07, 2006. Female patient, 52 years of age, weighting 151.0 lb, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: cardiac disorder, ejection fraction decreased. NOVANTRONE dosage: 14 MG EVERY 3 MONTHS IV DRIP. During the same period patient was treated with KYTRIL, BACLOFEN, CALCIUM GLUCONATE, GARLIC OIL CAPSULE, VITAMIN E, ADVIL. Patient recovered.

Novantrone Side Effects Report #5079218-3
NOVANTRONE problem was reported by a Consumer or non-health professional from UNITED STATES on July 28, 2006. Male patient, 54 years of age, weighting 188.0 lb, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: carotid artery occlusion, cerebrovascular accident. NOVANTRONE dosage: 12 MG, 1 IN 3 MONTHS, INTRAVENOUS. Patient was hospitalized and became disabled. Patient died on 07/28/2006.

Novantrone Side Effects Report #5081565-6
Health Professional from UNITED STATES reported NOVANTRONE problem on Aug 03, 2006. Male patient, 68 years of age, weighting 147.9 lb, was diagnosed with acute myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: enterococcal infection, febrile neutropenia, hypernatraemia, mucosal inflammation, pneumonia. NOVANTRONE dosage: unknown. During the same period patient was treated with ETOPOSIDE, CYTARABINE, ZOSYN, VANCOMYCIN, VALTREX, DEXAMETHASONE, LASIX. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5081952-6
NOVANTRONE problem was reported by a Health Professional from UNITED KINGDOM on July 28, 2006. Male patient, 60 years of age, was diagnosed with febrile neutropenia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: chills, dizziness, hypothermia. NOVANTRONE dosage: unknown. During the same period patient was treated with CHLORAMBUCIL, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5081955-1
Consumer or non-health professional from UNITED KINGDOM reported NOVANTRONE problem on July 31, 2006. Female patient, 54 years of age, was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, lymphocyte count decreased, neutropenic sepsis, platelet count decreased, red blood cell count decreased. NOVANTRONE dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, TRETINOIN. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5085015-5
NOVANTRONE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 03, 2006. Male patient, 59 years of age, weighting 159.6 lb, was diagnosed with acute myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: central line infection, febrile neutropenia, staphylococcal infection. NOVANTRONE dosage: 15 MG, 1 IN 1 DAYS, INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with ETOPOSIDE, CYTARABINE, VORICONZOLE, ALLOPURINOL, NORFLOXACIN, ACETAMINOPHEN, COLCHICUM JTL LIQ. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5086052-7
Consumer or non-health professional from FRANCE reported NOVANTRONE problem on Aug 09, 2006. Female patient, 16 years of age, was diagnosed with acute myelomonocytic leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal pain, acute respiratory distress syndrome, enterocolitis, hepatomegaly, infection, pancytopenia, pyrexia, renal failure acute. NOVANTRONE dosage: 19 MG, 1 IN 1 DAYS, INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with CYTARABINE, CHLORPROMAZINE HYDROCHLORIDE, ONDANSETRON, VANCOMYCIN, NEFOPAM HYDROCHLORIDE, ZOPICLONE, NOMEGESTROL ACETATE. Patient was hospitalized. Patient died on 05/11/2006.

Novantrone Side Effects Report #5088276-1
NOVANTRONE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 10, 2006. Male patient, 62 years of age, was diagnosed with acute myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: bilirubin conjugated increased, blood bilirubin increased, blood calcium decreased, fluid overload, hypovolaemia, infection, pneumonia, renal failure acute. NOVANTRONE dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, CYTARABINE, ETOPOSIDE. Patient died on 12/29/2004.

Novantrone Side Effects Report #5091421-5
Physician from UNITED STATES reported NOVANTRONE problem on Aug 15, 2006. Male patient, 59 years of age, weighting 191.0 lb, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, cardiomyopathy, dizziness, dyspnoea paroxysmal nocturnal, echocardiogram abnormal, ejection fraction decreased, low density lipoprotein increased. NOVANTRONE dosage: 23 MG, 1 IN 3 MONTHS. During the same period patient was treated with REBIF, BACLOFEN, PROVIGIL, TYLENOL, LYRICA, ZOLOFT, ROZEREM, PLETAL. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5092874-9
NOVANTRONE problem was reported by a Consumer or non-health professional from FRANCE on Aug 11, 2006. Female patient, 31 years of age, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: injection site haematoma, injection site pain, injection site pruritus. NOVANTRONE dosage: unknown. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5092877-4
Consumer or non-health professional from UNITED STATES reported NOVANTRONE problem on Aug 11, 2006. Female patient, 43 years of age, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: blood test abnormal, leukopenia, neutrophil count decreased, urinary tract infection. NOVANTRONE dosage: 12 MG/M2, 1 IN 3 MONTHS, INTRAVENOUS. During the same period patient was treated with NEUPOGEN. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5093216-5
NOVANTRONE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 17, 2006. Male patient, 36 years of age, weighting 175.0 lb, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, device failure, infusion related reaction, venous thrombosis limb. NOVANTRONE dosage: 9 MG/M2, 1 IN 3 MONTHS, INTRAVENOUS. Patient recovered.

Novantrone Side Effects Report #5096922-1
Consumer or non-health professional from UNITED STATES reported NOVANTRONE problem on Aug 21, 2006. Male patient, 61 years of age, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: pancreatic carcinoma, therapeutic response decreased. NOVANTRONE dosage: unknown. During the same period patient was treated with RITUXIMAB, CELLCEPT. Patient recovered.

Novantrone Side Effects Report #5096924-5
NOVANTRONE problem was reported by a Physician from UNITED STATES on Aug 24, 2006. Male patient, 42 years of age, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: coronary artery occlusion, myocardial infarction. NOVANTRONE dosage: 21.6 MG. During the same period patient was treated with COPAXONE, VITAMIN. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5096927-0
Consumer or non-health professional from UNITED STATES reported NOVANTRONE problem on Aug 25, 2006. Male patient, 36 years of age, weighting 175.0 lb, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: administration site reaction, deep vein thrombosis, infusion related reaction, medical device complication. NOVANTRONE dosage: 9 MG/M2, 1 IN 3 MONTHS, INTRAVENOUS (NOT OTHERWISE SPECIFIED). Patient recovered.

Novantrone Side Effects Report #5096993-2
NOVANTRONE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 21, 2006. Male patient, 81 years of age, weighting 160.1 lb, was diagnosed with acute myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: anorexia, blood alkaline phosphatase increased, blood culture positive, dysphagia, fatigue, febrile neutropenia, infection, pancytopenia, stomatitis. NOVANTRONE dosage: unknown. During the same period patient was treated with ETOPOSIDE, CYTARABINE, ACYCLOVIR, PREDTE. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5097368-2
Consumer or non-health professional from UNITED STATES reported NOVANTRONE problem on Aug 18, 2006. Female patient, 37 years of age, was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: chills, dermatitis exfoliative, face oedema. NOVANTRONE dosage: 20 MG, 1 IN 1 CYCLE, INTRAVENOUS. During the same period patient was treated with METHYLPREDNISOLONE SUCCINATE. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5100813-7
NOVANTRONE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 23, 2006. Female patient, 31 years of age, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: injection site haematoma, injection site pain, injection site pruritus. NOVANTRONE dosage: unknown. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5102857-8
Consumer or non-health professional from reported NOVANTRONE problem on Aug 31, 2006. Male patient, 67 years of age, was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: bronchopneumonia, cardio-respiratory arrest, respiratory failure, ventricular fibrillation. NOVANTRONE dosage: 14 MG,. During the same period patient was treated with CYTARABINE, ETOPOSIDE, TEICOPLANIN, MEROPENEM, ANTIFUNGALS. Patient died on 08/02/2006.

Novantrone Side Effects Report #5105073-9
NOVANTRONE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 30, 2006. Female patient, 40 years of age, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: acute promyelocytic leukaemia. NOVANTRONE dosage: unknown. Patient recovered.

Novantrone Side Effects Report #5106096-6
Health Professional from UNITED STATES reported NOVANTRONE problem on Aug 31, 2006. Female patient, 70 years of age, weighting 163.8 lb, was diagnosed with acute myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: aphasia, carotid artery aneurysm, cerebral artery occlusion, cerebral haemorrhage, cerebral ischaemia, cognitive disorder, lacunar infarction, mental status changes. NOVANTRONE dosage: unknown. During the same period patient was treated with ETOPOSIDE, CYTARABINE. Patient was hospitalized. Patient died on 08/21/2006.

Novantrone Side Effects Report #5107748-4
NOVANTRONE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 29, 2006. Female patient, 83 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, febrile neutropenia. NOVANTRONE dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, CYTARABINE, FLUDARABINE PHOSPHATE, FLUCONAZOLE, AMPHOTERICIN B, LEVOFLOXACIN, ITRACONAZOLE, CEFTAZIDIME. Patient recovered.

Novantrone Side Effects Report #5108433-5
Consumer or non-health professional from UNITED STATES reported NOVANTRONE problem on Sept 08, 2006. Male patient, 62 years of age, was diagnosed with acute myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: bilirubin conjugated increased, blood bilirubin increased, hypovolaemia, pneumonia, renal failure acute, respiratory distress, weight increased. NOVANTRONE dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, CYTARABINE, ETOPOSIDE, PANTOPRAZOLE, ACYCLOVIR, ACETAMINOPHEN, DIPHENHYDRAMINE, LORAZEPAM. Patient died on 12/29/2004.

Novantrone Side Effects Report #5108595-X
NOVANTRONE problem was reported by a Consumer or non-health professional from FRANCE on Aug 31, 2006. Female patient, 37 years of age, was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: chills, dermatitis exfoliative, face oedema. NOVANTRONE dosage: 20 MG, 1 IN 1 CYCLE, INTRAVENOUS. During the same period patient was treated with METHYLPREDNISOLONE SUCCINATE. Patient was hospitalized. Patient recovered.

Showing 1-100 of 312 Next >

Ask Our Patient Community about Novantrone